NYSE: AMWLAmerican Well Corp Stock
$7.96+0.07 (+0.89%)
Updated Mar 14, 2025
AMWL Price
$7.96
Fair Value Price
N/A
Market Cap
$124.26M
52 Week Low
$5.00
52 Week High
$18.80
P/E
-0.57x
P/B
0.41x
P/S
0.43x
PEG
N/A
Dividend Yield
N/A
Revenue
$254.36M
Earnings
-$208.14M
Gross Margin
38.9%
Operating Margin
-80.75%
Profit Margin
-81.8%
Debt to Equity
0.39
Operating Cash Flow
-$127M
Beta
1.42
Next Earnings
Apr 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
AMWL Overview
American Well Corp (Amwell) is a telemedicine company. It sells its platform as a subscription service to healthcare providers to put their medical professionals online. Its proprietary software development kits, APIs, and system integrations enable clients to embed telehealth into existing workflows utilized by providers and patients. The company was founded in 2006 and is based in Boston, MA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AMWL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
AMWL
Ranked#34 of 46
Ranked#34 of 46
Be the first to know about important AMWL news, forecast changes, insider trades & much more!
AMWL News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AMWL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMWL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AMWL is good value based on its book value relative to its share price (0.41x), compared to the US Health Information Services industry average (3.81x)
P/B vs Industry Valuation
AMWL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AMWL due diligence checks available for Premium users.
Valuation
AMWL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.57x
Industry
18.8x
Market
3,446.61x
AMWL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.41x
Industry
3.81x
AMWL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AMWL's financial health
Profit margin
Revenue
$71.0M
Net Income
-$42.7M
Profit Margin
-60.1%
AMWL's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
AMWL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$436.0M
Liabilities
$119.7M
Debt to equity
0.39
AMWL's short-term assets ($316.99M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMWL's short-term assets ($316.99M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMWL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AMWL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$13.4M
Investing
-$4.1M
Financing
-$2.0k
AMWL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AMWL vs Health Information Service Stocks
American Well Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.